Home > Products > CD3 & CD79B > Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (sdAb-Fc-sdAb)

Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (sdAb-Fc-sdAb)  (CAT#: HCAB-016)

Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (sdAb-Fc-sdAb, Tetravalent Heavy Chain-only Antibody, Tetravalent HCAb) is symmetric protein with two pairs of single domain antibodies (sdAb), from anti-CD3 and anti-CD79B antibodies, fused to the N-terminus and C-terminus of the Fc separately. This BsAb is bispecific, tetravelant, 2+2 antigen-binding valency. It can retarget T cells to tumor cells. It is designed for the research of Chronic lymphocytic leukemia (CLL); Non-Hodgkin's lymphoma (NHL); Diffuse large B cell lymphoma (DLBCL) therapy.
Datasheet INQUIRY

Specifications

Targets
CD3 & CD79B
Type
sdAb-Fc-sdAb
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Chronic lymphocytic leukemia (CLL); Non-Hodgkin's lymphoma (NHL); Diffuse large B cell lymphoma (DLBCL)
Host Animal 1
llama
Host Animal 2
llama

Targets

Target 1
CD3
Gene ID
UniProt ID
Alternative Names
CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3
Target 2
CD79B
Gene ID
UniProt ID
Alternative Names
CD8A; CD8a molecule; Cluster of differentiation 8; CD8; MAL; p32; Leu2
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD3 & CD79B"
See other bsAb targets related to "CD3"

See other bsAb targets related to "CD79B"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CD79B Bispecific Antibody (sdAb-Fc-sdAb) (HCAB-016). Click the button below to contact us or submit your feedback about this product.